Berberine enhances the antibacterial activity of selected antibiotics against coagulase-negative staphylococcus strains in vitro

Molecules

Volumn 19, Issue 5, 2014, Pages 6583-6596

  Wojtyczka, Robert D ^a   Dziedzic, Arkadiusz ^a   Kȩpa, Małgorzata ^a   Kubina, Robert ^a   Kabała Dzik, Agata ^a   Mularz, Tomasz ^a   Idzik, Danuta ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Antimicrobial activity; Berberine; Coagulase negative staphylococci (CoNS)

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; BERBERINE; COAGULASE; LINEZOLID; OXAZOLIDINONE DERIVATIVE;

DRUG EFFECTS; DRUG POTENTIATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BERBERINE; COAGULASE; DRUG SYNERGISM; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84901387433     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19056583     Document Type: Article

References (34)

1. ECDC/EMEA Joint Technical Report: The bacterial challenge: Time to react. ECDC/EMEA: Stockholm, Sweden, 2009. Available online: http://www.ecdc.europa. eu/en/publications/Publications/Forms/ECDC DispForm.aspx?ID=444 (accessed on 17 September 2009).
2. Vuong C.; Otto M. Staphylococcus epidermidis infections. Microbes Infect. 2002, 4, 481-489.
3. Kloos W.; Schleifer K.H. Staphylococcus. In Bergey's Manual of Systematic Bacteriology Sneath P.H.A., Ed.; Williams & Wilkins: Baltimore, MD, USA, 1986; Volume 2, pp. 1013-1035.
4. Imanshahidi M.; Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis. vulgaris and its active constituent. Phytother. Res. 2008, 22, 999-1012.
5. Tillhon M.; Guman Ortiz L.M.; Lombardi P.; Scovassi A.I. Berberine: New perspectives for old remedies. Biochem. Pharmacol. 2012, 84, 1260-1267.
6. Singh A.; Duggal S.; Kaur N.; Singh J. Berberine: Alkaloid with wide spectrum of pharmacological activities. J. Nat. Prod. 2010, 3, 64-75.
7. Vuddanda P.R.; Chakraborty S.; Singh S. Berberine: A potential phytochemical with multispectrum therapeutic activities. Expert Opin. Inv. Drug. 2010, 19, 1297-307.
8. Birdsall T.C.; Kelly G.S. Berberine: Therapeutic potential of an alkaloid found in several medicinal plants. Altern. Med. Rev. 1997, 2, 94-103.
9. Jin J.L.; Hua G.G.; Meng Z.; Gao P.J. Antibacterial mechanisms of berberine and reasons for little resistance of bacteria. Chin. Herb. Med. 2010, 3, 27-35.
10. Čerňákowá M.; Koštalová D. Antimicrobial activity of berberine-A constituent of Mahonia. aquifolium. Folia Microbiol. 2002, 47, 375-378.
11. Mantena S.K.; Sharma S.D.; Katiyar S.K. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in humane prostate carcinoma cell. Mol. Cancer Ther. 2006, 5, 296-308.
12. Zeng X.H.; Zeng X.J.; Li Y.Y. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 2003, 93, 173-176.
13. Yu H.H.; Kim K.J.; Cha J.D.; Kim H.K.; Lee Y.E.; Choi N.Y.; You Y.O. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillinresistant Staphylococcus aureus. J. Med. Food 2005, 8, 454-461.
14. Song W.; Woo H.J.; Kim J.S.; Lee K.M. In vitro activity of β-lactams, in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. Int. J. Antimicrobial Agents 2003, 21, 8-12.
15. Freilea M.L.; Giannini F.; Pucci G.; Sturniolo A.; Rodero L.; Pucci O.; Balzareti V.; Enriz R.D. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis. heterophylla. Fitoterapia 2003, 74, 602-705.
16. Li A.R.; Zhu Y.; Li X.N.; Tian X.J. Antimicrobial activity of four species of Berberidaceae. Fitoterapia 2007, 78, 379-381.
17. Zuo G.Y.; Li Y.; Han J.; Wang G.C.; Zhang Y.L.; Bian Z.Q. Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of Methicillin-Resistant Staphylococcus aureus (MRSA). Molecules 2012, 17, 10322-10330.
18. Musumeci R.; Speciale A.; Costanzo R.; Annino A.; Ragusa S.; Rapisarda A.; Pappalardo M.S.; Iauk L. Berberis aetnensis C. Presl. extracts: Antimicrobial properties and interaction with ciprofloxacin. Int. J. Antimicrobial Agents 2003, 22, 48-53.
19. Wojtyczka R.D.; Kȩpa M.; Idzik D.; Kubina R.; Kabała-Dzik A.; Dziedzic A.; Wa̧sik T.J. In vitro antimicrobial activity of ethanolic extract of Polish propolis against biofilm forming Staphylococcus epidermidis strains. Evid-Based Complement. Alternat. Med. 2013, doi:10.1155/2013/590703.
20. Wojtyczka R.D.; Dziedzic A.; Idzik D.; Kȩpa M.; Kubina R.; Kabała-Dzik A.; Smoleń-Dzirba J.; Stojko J.; Sajewicz M.; Wa̧sik T.J. Susceptibility of Staphylococcus aureus clinical isolates to propolis extract alone or in combination with antimicrobial drugs. Molecules 2013, 18, 9623-9640.
21. Wang X.; Yao X.; Zhu Z.; Tang T.; Dai K.; Sadovskaya I.; Flahaut S.; Jabbouri S. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int. J. Antimicrobial Agents 2009, 34, 60-66.
22. Chan B.C.; Ip M.; Lau C.B.; Lui S.L.; Jolivalt C.; Ganem-Elbaz C.; Litaudon M.; Reiner N.E.; Gong H.; See R.H.; et al. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J. Ethnopharmacol. 2011, 137, 767-773.
23. Sato Y.; Shibata H.; Arai T.; Yamamoto A.; Okimura Y.; Arakaki N.; Higuti T. Variation in synergistic activity by flavone and its related compounds on the increased susceptibility of various strains of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics. Int. J. Antimicrobial Agents 2004, 24, 226-233.
24. Petersen P.J.; Labthavikul P.; Jones C.H.; Bradford P.A. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J. Antimicrob. Chemother. 2006, 57, 573-576.
25. Wagner H.; Ulrich-Merzenich G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16, 97-110.
26. Stermitz F.R.; Lorenz P.; Tawara J.N.; Zenewicz L.A.; Lewis K. Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5''-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. USA 2000, 97, 1433-1437.
27. Ettefagh K.A.; Burns J.T.; Junio H.A.; Kaatz G.W.; Cech N.B. Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition. Planta Med. 2011, 77, 835-840.
28. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In Antibiotics in Laboratory Medicine, 5th ed.; Loman V., Ed.; Williams and Wilkins: Philadelphia, PA, USA, 2005; pp. 61-143.
29. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. EUCAST discussion document E.dis. 5.1. Clin. Microbiol. Infec. 2003, 9, 1-7.
30. Cudic M.; Condie B.A; Weiner D.J.; Lysenko E.S.; Xiang Z.Q.; Insug O.; Bulet P.; Otvos L., Jr. Development of novel antibacterial peptides that kill resistant clinical isolates. Peptides 2002, 23, 2071-2083.
31. Devienne K.F.; Raddi M.S.G. Screening for antimicrobial activity of natural Products using a microplate photometer. Braz. J. Microbiol. 2002, 33, 166-168.
32. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. EUCAST definitive document E. Def 1.2. Clin. Microbiol. Infec. 2000, 6, 503-508.
33. Fernandes A., Jr.; Balestrin E.C.; Betoni J.E.C.; Orsi R.O.; da Cunha M.R.S.; Montelli A.C. Propolis: Anti-Staphylococcus aureus activity and synergism with antimicrobial drugs. Memórias. Instituto. Oswaldo. Cruz 2005, 100, 563-566.
34. Mahon C.R.; Manuselis J.R.G. Textbook of Diagnostic Microbiology; W.B. Saunders: Philadelphia, PA, USA, 1995.